HCAT stock

Health Catalyst Inc (HCAT) support and resistance · rev $141.2M

Health Catalyst Inc (HCAT) is a health information services company listed on NASDAQ.

This page maps Health Catalyst Inc (HCAT) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported HCAT revenue for 2026-06-30 was $141.2M. Net income was -$151.6M. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. HCAT currently screens at market cap $130.8M.

HCAT currently screens at market cap $130.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new HCAT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the HCAT quote page for the session range and the stock page for the full model.

Not investment advice.

Full HCAT analysis